ARUP's Laboratory Test Directory

Hepatitis B Virus DNA Ultrasensitive Quantitative Real-Time PCR : 0056025

Mnemonic: HBVUPCR

Methodology: Real-Time Polymerase Chain Reaction
Performed: Sun-Sat
Reported: 2-4 days
Specimen Required: Collect:  One 7 mL serum separator tube, PPT, lavender (EDTA), or pink (K2EDTA).  (Min: 5 mL)

Transport:  2 mL serum or plasma, frozen. (Min: 0.5 mL)  Submit specimen in an ARUP Standard Transport Tube.  Specimens collected in a PPT should be submitted in original container.

Submit specimen according to Biological Substance, Category B, shipping guidelines.


Pediatric Collection/Transport:  0.25 mL serum or plasma, frozen.

Submit specimen according to Biological Substance, Category B, shipping guidelines.


Remarks:  CRITICAL FROZEN.  Separate specimens must be submitted when multiple tests are ordered.  Separate serum or plasma from cells within four hours. 

Unacceptable Conditions:  Nonfrozen specimens or specimens exposed to repeated freeze/thaw cycles. Heparinized specimens. Polystyrene tubes.

Stability:  Ambient: 4 hours (on cells); Plasma or serum removed from cells within four hours can be refrigerated and frozen as follows: Refrigerated: 24 hours; Frozen: 4 months
Reference Interval:
Not detected
Interpretive Data: The quantitative range of this assay is 1.6-8.3 log IU/mL (40-200,000,000 IU/mL). 

An interpretation of "Not Detected" does not rule out the presence of PCR inhibitors in the patient specimen or hepatitis B virus DNA concentrations below the level of detection of the assay.  Care should be taken when interpreting any single viral load determination.  In less than 1 percent of cases, low values (in the range of 1.6 to 2.8 log  IU/mL) may be seen in specimens from patients who are uninfected. 
 
1 IU/mL of HBV DNA is approximately 5 copies/mL.
1 IU/mL of HBV DNA is approximately 0.000018 pg/mL.

This assay should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cell, Tissues and Cellular Tissue-Based Products (HCT/P).


Please refer to Statement A in the Compliance Statements section in the front of the Laboratory Test Directory.
Note: This test is intended for use in conjunction with clinical presentation and other laboratory markers as an indicator of disease prognosis.  This test is also used as an aid in accessing viral response to treatment as measured by changes in HBV DNA levels. 
CPT Code(s): 87517
 
 

 

 

 
All ARUP Sites:        www.aruplab.com     ·     www.arupconsult.com     ·     www.arup.utah.edu     ·     www.childx.org     ·     www.utahblood.org